Table 1.
Characteristics of RCC samples analyzed by transcriptome- and proteome-based approaches.
| A: Details of the patients and samples. | ||||
|---|---|---|---|---|
| Group | Sex (m/f) | Mean age (y) | Clinical details | |
|
| ||||
| subtype | number | |||
|
|
||||
| oncocytoma | 1/1 | 49 (±11) | - | 2 |
|
| ||||
| leiomyosarcoma | 1/0 | 78 | - | 1 |
|
| ||||
| RCC | 20/12 | 62 (±24) | clear cell | 32 |
| 2/1 | 64 (±9) | chromophilic | 3 | |
| 0/2 | 58 (±16) | chromophobic | 2 | |
| B: Number of samples analyzed using different techniques | |||
|---|---|---|---|
| cDNA microarrays | classical proteomics | PROTEOMEX | |
| number of cases or cell lines (NN/RC) | 17/17 | 21/21 | 1/3 |
| number of serum samples (NN/RC) | - | - | 7/8 |
| number of targets | 119 | 334 | 50 |